Trial Profile
A Single-center, Randomized, Open, Single Dose Phase I Study to Access the Metabolite Identification and Material Balance in Health Volunteer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Retagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 09 Jul 2016 New trial record